St. Luke’s introduces advanced disease detection and cancer treatment technology
As part of its mission to provide a patient-centered experience guided by excellence and innovation, St. Luke’s Medical Center (SLMC) acquires three cutting-edge machines for its disease detection and cancer treatment services.
St. Luke’s is the first hospital in the Philippines to procure these world-class technologies from Siemens Healthineers and Varian. The two companies have recently merged as one to be the medical technology arm of Siemens AG. Siemens AG is the biggest industrial manufacturing company in Europe and has established Siemens Healthineers and Varian as leaders in healthcare technology.
The new systems will be dedicated to patients in need of comprehensive detection, diagnosis, and treatment for diseases that need radiation treatment and imaging, such as those with cancer.
SAFER AND MORE EFFECTIVE RADIOTHERAPY
The Halcyon LINAC provides safer and more effective radiotherapy for patients with cancer.
First of the three is the Halcyon linear accelerator (LINAC), a radiotherapy machine from Varian under the Department of Radiation Oncology — the cancer treatment facility of St. Luke’s. The Halcyon’s fully digitalized cutting-edge technology offers safer, quicker, and more effective radiation treatment for patients with cancer. This machine creates simplified but enhanced imaging for pinpoint accuracy while providing a relaxing treatment experience for the patient.
ADVANCED NUCLEAR MEDICINE SCANNERS FOR DETECTION OF CANCER AND OTHER DISEASES
The Symbia Intevo SPECT-CT can generate a combined nuclear medicine and CT image in a single scan.
To complement the Halcyon LINAC, St. Luke’s also has the Symbia Intevo SPECT-CT and Biograph Vision PET-CT under the Department of Nuclear Medicine. The two machines allow faster detection and diagnosis of diseases — with the Symbia Intevo capable of generating an anatomic and metabolic picture of the patient’s condition in just a single scan, detecting cancer metastases, cancer recurrence, cardiac ischemia, pulmonary embolism, and acute cholecystitis.
The Biograph Vision PET-CT scanner, on the other hand, accurately monitors and determines the extent of cancer. These machines allow St. Luke’s expert physicians make accurate decisions in their treatment strategies.
Biograph Vision PET-CT is focused on advanced monitoring of a patient’s cancer.
Similar to the Halcyon LINAC, the SPECT/CT and PET/CT scanners offer a more comfortable patient experience with lesser radiation exposure to the patient.
St. Luke’s Department of Radiation Oncology and Department of Nuclear Medicine play crucial roles in the detection, diagnosis, and treatment of patients suffering from diseases invisible to the naked eye. With its investment in better technology, St. Luke’s continues its commitment to save lives and provide the best possible patient care.
For patient safety, all machines are thoroughly sanitized after every use as part of the hospital’s strict safety protocols amid the COVID-19 pandemic. COVID-positive patients also use separate machines from COVID-negative patients to avoid virus transmission.
For appointments and queries on radiation treatment, patients may contact St. Luke’s Department of Radiation Oncology at 8-723-0101 local 5414 (Quezon City) or 8-789-7700 local 5413 (Global City).
For PET/CT and SPECT/CT services, patients may contact St. Luke’s Department of Nuclear Medicine at 8-723-0101 local 4151 (Quezon City) or St. Luke’s Nuclear Medicine & PET Center at 8-789-7700 local 1004/1152 (Global City).
ADVT.
